{
  "title": "Paper_584",
  "abstract": "pmc BMC Cancer BMC Cancer 16 bmccanc BMC Cancer 1471-2407 BMC PMC12482668 PMC12482668.1 12482668 12482668 41029235 10.1186/s12885-025-14794-6 14794 1 Research Automated contouring of gross tumor volume lymph nodes in lung cancer by deep learning Huang Yuling 1 2 Yuan Xingxing 1 2 Xu Longfei 1 2 Jian Junming 1 2 Gong Changfei 1 2 Zhang Yun 1 2 3 Zheng Wenheng zhengwh06@foxmail.com 1 2 1 https://ror.org/00v8g0168 grid.452533.6 0000 0004 1763 3891 Department of Radiation Oncology, Jiangxi Cancer Hospital, 2 https://ror.org/015qzwq73 grid.452764.6 0000 0004 1770 0177 The Second Affiliated Hospital of Nanchang Medical College, 3 https://ror.org/00v8g0168 grid.452533.6 0000 0004 1763 3891 JXHC Key Laboratory of Tumor Microenvironment and Immunoregulation, Jiangxi Cancer Hospital, 30 9 2025 2025 25 478185 1444 29 2 2024 1 8 2025 30 09 2025 01 10 2025 02 10 2025 © The Author(s) 2025 2025 https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access http://creativecommons.org/licenses/by-nc-nd/4.0/ Purpose The precise contouring of gross tumor volume lymph nodes (GTVnd) is an essential step in clinical target volume delineation. This study aims to propose and evaluate a deep learning model for segmenting GTVnd specifically in lung cancer, representing one of the pioneering investigations into automated segmentation of GTVnd specifically for lung cancer. Method Ninety computed tomography (CT) scans of patients with stage Ш-Ⅳ small cell lung cancer (SCLC) were collected, of which 75 patients were assembled into a training dataset and 15 were used in a testing dataset. A new segmentation model was constructed to enable the automatic and accurate delineation of the GTVnd in lung cancer. This model integrates a contextual cue enhancement module and an edge-guided feature enhancement decoder. The contextual cues enhancement module was used to enforce the consistency of the contextual cues encoded in the deepest feature, and the edge-guided feature enhancement decoder was used to obtain edge-aware and edge-preserving segmentation predictions. The model was quantitatively evaluated using the three-dimensional Dice Similarity Coefficient (3D DSC) and the 95th Hausdorff Distance (95HD). Additionally, comparative analysis was conducted between predicted treatment plans derived from auto-contouring GTVnd and established clinical plans. Results The ECENet achieved a mean 3D DSC of 0.72 ± 0.09 and a 95HD of 6.39 ± 4.59 mm, showing significant improvement compared to UNet, with a DSC of 0.46 ± 0.19 and a 95HD of 12.24 ± 13.36 mm, and nnUNet, with a DSC of 0.52 ± 0.18 and a 95HD of 9.92 ± 6.49 mm. Its performance was intermediate, falling between mid-level physicians, with a DSC of 0.81 ± 0.06, and junior physicians, with a DSC of 0.68 ± 0.10. And the clinical and predicted treatment plans were further compared. The dosimetric analysis demonstrated excellent agreement between predicted and clinical plans, with average relative deviation of < 0.17% for PTV D2/D50/D98, < 3.5% for lung V30/V20/V10/V5/Dmean, and < 6.1% for heart V40/V30/Dmean. Furthermore, the TCP (66.99% ± 0.55 vs. 66.88% ± 0.45) and NTCP (3.13% ± 1.33 vs. 3.25% ± 1.42) analyses revealed strong concordance between predicted and clinical outcomes, confirming the clinical applicability of the proposed method. Conclusion The proposed model could achieve the automatic delineation of the GTVnd in the thoracic region of lung cancer and showed certain advantages, making it a potential choice for the automatic delineation of the GTVnd in lung cancer, particularly for young radiation oncologists. Keywords Automatic segmentation Gross target volume lymph nodes (GTVnd) Lung cancer Deep learning Jiangxi Cancer Hospital Scientific Research Open Fund Project KFJJ2023YB19 Huang Yuling Science and Technology Research Project of Jiangxi Provincial Department of Education No.GJJ2203558 Huang Yuling Science and Technology Project of Jiangxi Provincial Health Commission of China No.202310054 Huang Yuling Jiangxi Cancer Hospital Doctoral Research Start-up Fund BSQDJ202301 Zheng Wenheng pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes issue-copyright-statement © BioMed Central Ltd., part of Springer Nature 2025 Introduction In recent years, lung cancer has become the second most common cancer with the highest mortality rate in the world [ 1 2 3 4 5 6 7 8 With the development of deep learning, convolutional neural network (CNN)-based methods have been successfully applied to the automatic contouring of lung cancer. Significant progress has been made in the study of automatic organ-at-risk (OAR) segmentation [ 9 11 12 13 14 15 16 17 18 The autodelineation of the GTVnd is difficult because of its unclear boundaries and variability in the size and shape. Although UNet, which was based on encoder-decoder architecture, has shown effective performance in conducting multilevel feature fusions, the network is insufficient to represent high-level features, particularly structures that are of significant importance for GTVnd recognition. Therefore, we propose a novel edge-guided contextual cue enhancement network (ECENet) to improve the segmentation performance of the GTVnd by introducing a contextual cue module and incorporating edge guidance into the feature learning of the segmentation network. A contextual cue modeling module is implemented to enhance spatial and semantic information at a distance. This study applies a deep learning approach to delineate lung cancer GTVnd, evaluating automated segmentation quality across geometric, dosimetric, and TCP/NTCP computational metrics. Methods Patient datasets Eligible patients had histologically confirmed stage III-IV small cell lung cancer (SCLC), complete baseline thoracic CT scans (defined as coverage of entire lung parenchyma, primary tumor, and involved lymph nodes without severe artifacts), and receipt of concurrent chemoradiotherapy comprising intensity-modulated radiotherapy (IMRT; 60 Gy/30 fractions at 2 Gy/fraction, 5 fractions/week) with platinum-based chemotherapy. Among 90 patients meeting these criteria treated between January 2021-January 2024, all had documented GTVnd delineation data. The number of slices per patient ranged from 70 to 105, with a total of 8,758 slices. The data were 512 × 512, with a pixel pitch of 1.27 × 1.27 mm and a thickness of 5 mm, and they were acquired using a Brilliance CT Big Bore (Siemens Healthcare). The private information of the patients was kept confidential during data collection and processing. GTVnd was defined as the area of the LN stations with a maximum short axis of > 1 cm. The GTVnd was delineated in the mediastinal and lung windows according to Radiation Therapy Oncology Group (RTOG) guidelines [ 19 Architecture of ECENet As shown in Fig. 1 20  Fig. 1 Overall network structure of the ECENet  Contextual cues enhancement module. The proposed contextual cue enhancement module consists of convolution kernel prediction and contextual cue aggregation submodules. As shown in Fig. 2  Fig. 2 Details of the proposed contextual cues enhancement module Concretely, for the deepest feature \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{X}\\in\\:{\\text{R}}^{\\text{H}\\times\\:\\text{W}\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{X}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{K}\\in\\:{\\text{R}}^{\\text{H}\\times\\:\\text{W}\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{Q}\\in\\:{\\text{R}}^{\\text{H}\\times\\:\\text{W}\\times\\:{\\text{s}}^{2}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{K}^{{\\prime\\:}}\\in\\:{\\text{R}}^{(\\text{H}\\times\\:\\text{W})\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{Q}^{{\\prime\\:}}\\in\\text{R}^{(\\mathrm H\\times\\mathrm W)\\times\\mathrm s^2}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{\\text{s}}^{2}$$\\end{document} 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{S}^{'}\\left(\\text{i},\\text{j}\\right)=\\sum\\:_{\\text{q}=1}^{\\text{H}\\times\\:\\text{W}}\\text{Q}'\\left(\\text{q},\\text{i}\\right)\\times\\:\\text{K}'\\:(\\text{q},\\text{j})$$\\end{document} where \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{i}=\\text{1,2},\\dots\\:,{\\text{s}}^{2}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{j}=\\text{1,2},\\dots\\:,\\text{C}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{\\text{S}}^{{\\prime\\:}}$$\\end{document} 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{S}^{'\\:}={\\text{Q}'\\:}^\\text{T}\\times\\:\\text{K}'\\:$$\\end{document} where \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{\\text{S}}^{{\\prime\\:}}\\in\\:{\\text{R}}^{{\\text{s}}^{2}\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{\\text{Q}'\\:}^\\text{T}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{Q}'\\:$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{\\text{S}}^{{\\prime\\:}}\\in\\:{\\text{R}}^{{\\text{s}}^{2}\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{S}\\in\\:{\\text{R}}^{\\text{s}\\times\\:\\text{s}\\times\\:\\text{C}}$$\\end{document} Furthermore, to generate the spatially adaptive weight factor \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{M}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{S}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{X}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{S}\\in\\:{\\text{R}}^{\\text{s}\\times\\:\\text{s}\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{s}\\times\\:\\text{s}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{X}\\in\\:{\\text{R}}^{\\text{H}\\times\\:\\text{W}\\times\\:\\text{C}}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{M}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:\\text{X}$$\\end{document}  (2) Edge-guided feature enhancement. The decoder is designed to effectively combine the multiscale features generated by the encoder in a layer-wise manner. In this process, for the lowest three layers, both the mask of the GTVnd region and the edge of the GTVnd region are used for supervisions. The features of the decoder learn to predict the segmentation mask and edge of the GTVnd simultaneously. In this manner, the learned edge-aware features can generate edge-preserving predictions. To obtain the ground truth of the edge of the GTVnd, we use the following operations to transform the mask of the GTVnd into the edge of the GTVnd. For each pixel, if the ground truth label of this pixel is different from that of any one of the eight neighboring pixels, then this pixel is an edge pixel.  (3) Loss function. To supervise the mask learning of the proposed ECENet, the widely used binary segmentation loss function is used, which is formulated as follows: 3 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{L}_{mask}=\\:-\\frac{1}{N}\\sum\\:_{i=1}^{N}[{y}_{i}\\text{log}\\left({p}_{i}\\right)+(1-{y}_{i})\\text{l}\\text{o}\\text{g}(1-{p}_{i}\\left)\\right]$$\\end{document} where \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{y}_{i}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{p}_{i}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:i$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:N$$\\end{document} Moreover, since we introduce the edge guidance into the feature learning of decoder network, the edge loss function is also employed to supervise the edge-aware feature learning, which is formulated as follows: 4 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{L}_{edge}=\\:-\\frac{1}{N}\\sum\\:_{i=1}^{N}[{e}_{i}\\text{log}\\left({q}_{i}\\right)+(1-{e}_{i})\\text{l}\\text{o}\\text{g}(1-q\\left)\\right]$$\\end{document} where \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{e}_{i}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:i$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:{q}_{i}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:i$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\:N$$\\end{document} Experiments Complete CT image data were randomly divided into a training dataset containing 75 cases and a testing dataset containing 15 cases in a ratio of 5:1. ECENet was trained for GTVnd contouring with the 75 cases in the training dataset and it was applied to predict 15 cases in the testing dataset. Stochastic gradient descent was used in the optimization, and the initial learning rate was set to 0.001. An NVIDIA RTX 4090 GPU was used in the experiments. Because ECENet was developed based on UNet, the performance of this model in contouring the GTVnd in lung cancer was comprehensively evaluated by comparing its performance with that of UNet. UNet, proposed by Ronneberger et al., features a symmetric encoder-decoder architecture for medical image segmentation. Its skip connections fuse shallow encoder features with deep decoder outputs, resolving downsampling-induced information loss. UNet was trained separately for GTVnd contouring under the same settings as ECENet. As an established benchmark in medical image segmentation, nnUNet was incorporated into our comparative analysis under identical experimental settings to ensure a rigorous performance evaluation [ 21 Quantitative evaluation metrics To quantify the contouring accuracy, the Dice Similarity Coefficient (DSC) [ 22 23 5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$DSC\\left(A,\\;B\\right)=\\frac{2\\left|A\\cap B\\right|}{\\left|A\\right|+\\left|B\\right|}$$\\end{document} where A B A B A B The 95 HD is defined as: 6 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{c}\\:95HD\\left(A,B\\right)\\text{=percentile}\\left[h\\left(A,B\\right)\\cup\\:h\\left(B,A\\right),95th\\right]\\\\h\\left(A,B\\right)=\\underset{a\\in\\:A}{max}\\underset{b\\in\\:B}{min}\\left\\|a-b\\right\\|\\\\\\:h\\left(B,\\;A\\right)=\\underset{b\\in\\:B}{max}\\underset{a\\in\\:A}{min}\\left\\|b-a\\right\\|\\end{array}\\\\\\\\\\\\$$\\end{document} where \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\| . \\right\\|$$\\end{document} A B A 1 2 n1 B 1 2 n2 A B Plan evaluation A comparative analysis was performed between the predicted treatment plans generated from auto-contoured GTVnd and established clinical plans. The predicted doses were derived from reoptimized plans, which were refined using the auto-contoured GTVnd and the original clinical target volume of the primary tumor (CTV-T). The total dose-volume histogram (DVH) curves of planned target volume (PTV) and distinct OARs were first exhibited between the prediction and clinical truth plans in terms of DVH parameters. Second, the clinically relevant dosimetric indices (DI) were determined, including the mean dose (Dmean), D2, D50, and D98 for PTV (where Di represents the dose received by i percent of PTV volume) and Dmean, V40, V30, V20, V10 and V5 for OARs (where Vi represents the volume fraction of OARs irradiated by i Gy). The following formula was used to calculate the homogeneity index (HI) and conformation index (CI) where V ptv V pres V ref 7 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{gathered} HI{\\text{=}}\\frac{{D2{\\text{-}}D98}}{{D50}} \\hfill \\\\ CI=\\frac{{{V_{ref}} * {V_{ref}}}}{{{V_{ptv}} * {V_{pre}}}} \\hfill \\\\ \\end{gathered}$$\\end{document} Equivalent Uniform Dose (EUD) EUD is defined as the dose absorbed with a biological effect similar to nonhomogeneous irradiation, if applied uniformly to the tumour or normal tissue [ 24 8 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{gathered} EUD{\\text{=}}{\\left( {\\sum\\nolimits_{{i=1}} {{V_i}EQ{D_i}^{{\\text{a}}}} } \\right)^{{1 \\mathord{\\left/ {\\vphantom {1 a}} \\right. \\kern-0pt} a}}} \\hfill \\\\ EQ{D_i}={D_i}\\frac{{\\frac{\\alpha }{\\beta }{\\text{+}}\\frac{{{D_i}}}{{{n_f}}}}}{{\\frac{\\alpha }{\\beta }{\\text{+2}}}} \\hfill \\\\ \\end{gathered}$$\\end{document} where EQD i V i D i n f D i n f α/β The Poisson distribution is used to derive the Poisson linear quadratic model [ 25 9 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$TCP{\\text{=}}{\\left[ {\\frac{1}{2}} \\right]^{\\sum\\nolimits_{i} {{V_i}*\\exp \\left[ {\\frac{{2\\gamma \\left( {1 - \\frac{{EQD2}}{{D50}}} \\right)}}{{\\ln 2}}} \\right]} }}$$\\end{document} where D50 γ EQD2 Lyman-Kutcher-Burman (LKB) is used to estimate the complication probability for the heterogeneously irradiated normal organs [ 26 10 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{gathered} NTCP{\\text{=}}\\frac{1}{{\\sqrt {2\\pi } }}\\int\\limits_{{ - \\infty }}^{t} {{e^{ - \\frac{{{x^2}}}{2}}}dx} \\hfill \\\\ t=\\frac{{{D_{eff}} - T{D_{50}}}}{{m * T{D_{50}}}} \\hfill \\\\ {D_{eff}}={\\left( {\\sum\\nolimits_{i} {{V_i}*D_{i}^{{\\frac{1}{n}}}} } \\right)^n} \\hfill \\\\ \\end{gathered}$$\\end{document} where TD50 V i i D i m n Results Fig. 3  Fig. 3 Example of GTVnd segmentation slice for a patient predicted from UNet, nnUNet and ECENet. A B C The 3D DSC and 95HD were calculated at a 3D level for the testing dataset and the mean ± standard deviation (SD) values for UNet, nnUNet and ECENet were calculated by averaging the values. The quantitative evaluation results were summarized in Table 1 P P  Table 1 The statistics of 3D DSC and 95HD with the volume of the GTVnd for unet, NnUnet and ECENet in the testing dataset DSC(mean ± SD) 95HD ± SD (mm) UNet 0.46 ± 0.19 12.24 ± 13.36 nnUnet 0.52 ± 0.18 9.92 ± 6.49 ECENet 0.72 ± 0.09 6.39 ± 4.59 The contouring accuracy of ECENet was benchmarked against radiation oncologists stratified by clinical experience: ​senior physicians​ (> 10 years, n n n The clinical DVH of the PTVs and OARs were compared to the predicted DVHs for the testing dataset. All treatment plans were optimized using the Eclipse™ treatment planning system (Varian Medical Systems) with inverse planning methodology. A prescription dose of 60 Gy in 30 fractions (2 Gy per fraction) was delivered over 6 weeks using intensity-modulated radiotherapy (IMRT), with 95% of the planning target volume (PTV) receiving 100% of the prescribed dose. Dose constraints adhered to RTOG 0617 protocols for normal tissues. The results revealed that there was an acceptable agreement between the clinical and predicted DVHs of the PTV and OARs. The mean and standard deviation of the clinically relevant DI for PTV and OARs in the testing dataset are presented in Table 2 P 4 5 Table 2 The statistics of dosimetric parameters and TCP/NTCP in testing dataset Clinical Prediction P PTV D98(Gy) 59.22 ± 0.22 59.20 ± 0.48 0.875 D50(Gy) 61.94 ± 0.41 61.91 ± 0.34 0.925 D2(Gy) 63.32 ± 0.54 63.21 ± 0.30 0.440 HI 0.066 ± 0.011 0.065 ± 0.010 0.700 CI 0.851 ± 0.017 0.830 ± 0.069 0.280 TCP 66.99 ± 0.55 66.88 ± 0.45 0.776 Lung V30(%) 43.14 ± 10.09 43.74 ± 9.56 0.125 V20(%) 32.54 ± 8.45 33.19 ± 8.07 0.078 V10(%) 22.16 ± 6.82 22.48 ± 6.57 0.394 V5(%) 12.68 ± 5.99 13.13 ± 6.06 0.100 Dmean(Gy) 11.10 ± 3.00 11.28 ± 3.05 0.061 NTCP 3.13 ± 1.33 3.25 ± 1.42 0.105 Heart V40(%) 13.17 ± 8.97 13.32 ± 8.89 0.510 V30(%) 7.35 ± 6.55 7.80 ± 6.55 0.151 V20(%) 4.46 ± 5.01 4.93 ± 5.18 0.133 Dmean(Gy) 6.92 ± 4.02 7.15 ± 4.15 0.173 Abbreviations: DI Dmean HI CI TCP NTCP Fig. 4 Comparison of DVHs for the clinical plan (solid triangle) and predicted plan (solid square) for a representative case Fig. 5 Clinical versus predicted treatment plans for a representative case. The predicted plans based on the autocontoured GTVnd. PTV is displayed as a blue-shaded region, GTVnd is delineated by red contours within the PTV Discussion Few studies have been conducted on the automatic delineation of the GTVnd for LN metastasis in lung cancer, and oncologists mainly perform manual contours based on their clinical experience, which leads to heterogeneity between different oncologists and intra-observers at different times [ 27 28 29 The DSC value was commonly used to assess the accuracy of auto-segmentation during radiation treatment planning. Because ECENet was developed based on UNet, its performance in contouring the GTVnd in lung cancer was comprehensively evaluated by comparing it with UNet. Furthermore, to ensure a comprehensive evaluation, the state-of-the-art nnUNet framework was included in the comparison under identical experimental conditions. As shown in Table 1 The performance of the ECENet was intermediate, achieving accuracy levels between those of mid-level and junior physicians. This model can serve as a reliable tool assist junior physicians, particularly in reducing inter-observer variability and improving workflow efficiency. However, there remains room for further improvement when compared to the performance of senior physicians, highlighting the need for continued refinement to bridge this gap and enhance the model's ability to capture complex anatomical details. Due to clinical constraints, intra-observer variability was not assessed. Although discrepancies were observed in GTVnd contouring between the auto-segmentation model and manual clinical delineation, ​dosimetric comparisons demonstrated clinically negligible differences​ between predicted and clinical plans for PTV coverage. This consistency may be attributed to the ​dominant volumetric contribution​ of the primary tumor clinical target volume (CTV-T), which ​diluted the impact​ of GTVnd variations from either auto-segmentation or manual delineation. For the illustrative case in Fig. 4 In the context of GTVnd segmentation, the DSC values have been reported to be 0.46 [ 30 31 Although the segmentation accuracy of GTVnd is better than the previously reported, it still displays inferior performance compared with the published GTV or OAR contouring models [ 32 34 Although the proposed ECENet model in this study demonstrates relatively high accuracy and potential in the automatic segmentation of lung cancer GTVnd, its primary limitation lies in the small scale of the dataset. The specific manifestations are as follows: Firstly, this was a single-center study with a relatively small sample size, and the segmentation accuracy of ECENet for GTVnd was inferior compared to that of the reported GTV or OAR contouring. Nevertheless, the proposed model achieves a higher DSC value in GTVnd segmentation tasks than previously reported models. Since Zijdenbos et al. suggested that a DSC value of >0.7 represents good overlap [ 35 In general, this model can provide a potential benefit for the automatic contouring of GTVnd in lung cancer. In the future, the dataset size could be expanded to further optimize the model and improve its applicability and overall accuracy. Simultaneously, this technology can be explored for the automatic segmentation of GTVnd in other types of tumors. Conclusion The automatic and accurate segmentation of the GTVnd is key to achieving the automatic delineation of the CTV for lung cancer with LN metastasis. In this study ECENet was proposed for the fully automatic and accurate contouring of GTVnd in lung cancer. The model was based on UNet with edge guidance and spatial context enhancement. The quantitative evaluation results demonstrated that the proposed method achieved acceptable accuracy for GTVnd contour delineation, with predicted dose distributions showing strong agreement with clinical ground truth data. These findings suggest that the automated GTVnd contouring approach exhibits significant potential for clinical implementation in radiotherapy treatment planning. However, a multicenter clinical evaluation with more cases is needed to fully apply the model in clinical practice. In conclusion, this study explored the application of deep learning to the automatic delineation of the GTVnd in lung cancer. ECENet has shown promising potential in terms of contouring accuracy, offering a robust framework that could significantly contribute to the automation of GTVnd delineation. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Authors’ contributions Huang, Zheng and Gong wrote the main manuscript text and Jian prepared figures. Yuan, Zhang and Xu collection and processing data. All authors reviewed the manuscript. Funding This work was supported by Science and Technology Research Project of Jiangxi Provincial Department of Education (No.GJJ2203558), Science and Technology Project of Jiangxi Provincial Health Commission of China (No.202310054), Jiangxi Cancer Hospital Doctoral Research Start-up Fund (No. BSQDJ202301) and the Jiangxi Cancer Hospital Scientific Research Open Fund Project (No. KFJJ2023YB19). Data availability The data are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was approved by the ethics committee of the Jiangxi Cancer Hospital (2023ky192) and individual informed consent for this study was waived for this retrospective analysis. All procedures were conducted in accordance with the principles outlined in the Declaration of Helsinki. Consent for publication Not Applicable. Competing interests The authors declare no competing interests. References 1. Sung H Ferlay J Siegel RL Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2021 71 3 209 49 33538338 10.3322/caac.21660 Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. 33538338 10.3322/caac.21660 2. Van Rikxoort EM de Hoop B Viergever MA Automatic lung segmentation from thoracic computed tomography scans using a hybrid approach with error detection Med Phys 2009 36 7 2934 47 10.1118/1.3147146 19673192 Van Rikxoort EM, de Hoop B, Viergever MA, et al. Automatic lung segmentation from thoracic computed tomography scans using a hybrid approach with error detection. Med Phys. 2009;36(7):2934–47. 19673192 10.1118/1.3147146 3. Ettinger DS Wood DE Akerley W Bazhenova LA Borghaei H Camidge DR Non-small cell lung cancer, version 6.2015 J Natl Compr Cancer Netw 2015 13 5 515 24 10.6004/jnccn.2015.0071 25964637 Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, et al. Non-small cell lung cancer, version 6.2015. J Natl Compr Cancer Netw. 2015;13(5):515–24. 10.6004/jnccn.2015.0071 25964637 4. De Ruysscher D Faivre-Finn C Nestle U Hurkmans CW Le Péchoux C Price A European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer J Clin Oncol 2010 28 36 5301 10 10.1200/JCO.2010.30.3271 21079134 De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le Péchoux C, Price A, et al. European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol. 2010;28(36):5301–10. 21079134 10.1200/JCO.2010.30.3271 5. Petersen H Holdgaard PC Madsen PH FDG PET/CT in cancer: comparison of actual use with literature-based recommendations Eur J Nucl Med Mol Imaging 2016 43 695 706 10.1007/s00259-015-3217-0 26519292 PMC4764641 Petersen H, Holdgaard PC, Madsen PH, et al. FDG PET/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging. 2016;43:695–706. 26519292 10.1007/s00259-015-3217-0 PMC4764641 6. Fletcher JW Djulbegovic B Soares HP Recommendations on the use of 18F-FDG PET in oncology J Nucl Med 2008 49 480 508 10.2967/jnumed.107.047787 18287273 Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480–508. 18287273 10.2967/jnumed.107.047787 7. Benjamin E Nelms WA Tomé G Robinson Jameswheeler Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer Int J Radiat Oncol Biol Phys 2010 82 1 368 78 21123004 10.1016/j.ijrobp.2010.10.019 Benjamin E, Nelms WA, Tomé G, Robinson James wheeler. Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2010;82(1):368–78. 21123004 10.1016/j.ijrobp.2010.10.019 8. Coen Rasch A Eisbruch Irradiation of paranasal sinus tumors, a delineation and dose comparison study[J] Int J Radiat Oncol Biol Phys 2002 52 1 120 7 10.1016/S0360-3016(01)01751-5 11777629 Coen Rasch A, Eisbruch, et al. Irradiation of paranasal sinus tumors, a delineation and dose comparison study[J]. Int J Radiat Oncol Biol Phys. 2002;52(1):120–7. 11777629 10.1016/s0360-3016(01)01751-5 9. Uzelaltinbulat S Ugur B Lung tumor segmentation algorithm Procedia Comput Sci 2017 120 140 7 10.1016/j.procs.2017.11.221 Uzelaltinbulat S, Ugur B. Lung tumor segmentation algorithm. Procedia Comput Sci. 2017;120:140–7. 10. Soltani-nabipour J Khorshidi A Noorian B Lung tumor segmentation using improved region growing algorithm Nucl Eng Technol 2020 52 10 2313 9 10.1016/j.net.2020.03.011 Soltani-nabipour J, Khorshidi A, Noorian B. Lung tumor segmentation using improved region growing algorithm. Nucl Eng Technol. 2020;52(10):2313–9. 11. Bolan Yang, Dehui Xiang, Feihong Yu, et al. Lung tumor segmentation based on the multi-scale template matching and region growing, Proc. SPIE 10578, Medical Imaging 2018: Biomedical Applications in Molecular, Structural, and Functional Imaging. 2018;105782Q. 10.1117/12.2293065. 12. H. Mi, C. Petitjean, B. Dubray, P. Vera and S. Ruan. Automatic lung tumor segmentation on PET images based on random walks and tumor growth model. Beijing, China: 2014 IEEE 11th International Symposium on Biomedical Imaging (ISBI); 2014. pp. 1385–8. 10.1109/ISBI.2014.6868136. 13. Y. Nian et al. Graph-based unsupervised segmentation for lung tumor CT images. Chengdu, China: 2017 3rd IEEE International Conference on Computer and Communications (ICCC); 2017. pp. 1884–8. 10.1109/CompComm.2017.8322865. 14. Oda H, Roth HR, Bhatia KK, et al. Dense volumetric detection and segmentation of mediastinal lymph nodes in chest CT images. In K Mori, & N Petrick (Eds.), Medical Imaging 2018: Computer-Aided Diagnosis Article 1057502 (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 10575). SPIE. 10.1117/12.2287066. 15. Ibragimov B Xing L Segmentation of organs-at-risks in head and neck CT images using convolutional neural networks Med Phys 2017 44 2 547 57 10.1002/mp.12045 28205307 PMC5383420 Ibragimov B, Xing L. Segmentation of organs-at-risks in head and neck CT images using convolutional neural networks. Med Phys. 2017;44(2):547–57. 10.1002/mp.12045. 28205307 10.1002/mp.12045 PMC5383420 16. Ronneberger O, Fischer P, Brox T, UNet. Convolutional networks for biomedical image segmentation[C]//International Conference on Medical Image Computing and Computer Assisted Intervention, 2015, 9351: 234–241. 17. Shen J Zhang F Di M Clinical target volume automatic segmentation based on lymph node stations for lung cancer with bulky lump lymph nodes Thorac Cancer 2022 13 20 2897 903 10.1111/1759-7714.14638 36085253 PMC9575127 Shen J, Zhang F, Di M, et al. Clinical target volume automatic segmentation based on lymph node stations for lung cancer with bulky lump lymph nodes. Thorac Cancer. 2022;13(20):2897–903. 36085253 10.1111/1759-7714.14638 PMC9575127 18. Skett S Autocontouring of primary lung lesions and nodal disease for radiotherapy based only on computed tomography images Phys Imaging Radiat Oncol 2024 31 100637 10.1016/j.phro.2024.100637 39297080 PMC11408859 Skett S, et al. Autocontouring of primary lung lesions and nodal disease for radiotherapy based only on computed tomography images. Phys Imaging Radiat Oncol. 2024;31: 100637. 39297080 10.1016/j.phro.2024.100637 PMC11408859 19. Bradley JD Paulus R Komaki R Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncol 2015 16 2 187 99 10.1016/S1470-2045(14)71207-0 25601342 PMC4419359 Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187–99. 25601342 10.1016/S1470-2045(14)71207-0 PMC4419359 20. Ronneberger O, Fischer P, Brox T, UNet. Convolutional networks for biomedical image segmentation. arXiv preprint arXiv:1505.04597, 2015. 21. Isensee F Jaeger PF Kohl SAA NnU-net: a self-configuring method for deep learning-based biomedical image segmentation Nat Methods 2021 18 203 11 10.1038/s41592-020-01008-z 33288961 Isensee F, Jaeger PF, Kohl SAA, et al. NnU-net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18:203–11. 10.1038/s41592-020-01008-z. 33288961 10.1038/s41592-020-01008-z 22. Dice LR Measures of the amount of ecologic association between species Ecology 1945 26 3 297 302 10.2307/1932409 Dice LR. Measures of the amount of ecologic association between species. Ecology. 1945;26(3):297–302. 23. Huttenlocher DP Klanderman GA Rucklidge WJ Comparing images using the hausdorff distance IEEE Trans Pattern Anal Mach Intell 1993 15 9 850 63 10.1109/34.232073 Huttenlocher DP, Klanderman GA, Rucklidge WJ. Comparing images using the hausdorff distance. IEEE Trans Pattern Anal Mach Intell. 1993;15(9):850–63. 24. Mercieca S Belderbos JSA van Baardwijk A The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study Acta Oncol 2019 58 2 200 8 10.1080/0284186X.2018.1529422 30375905 Mercieca S, Belderbos JSA, van Baardwijk A, et al. The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study. Acta Oncol. 2019;58(2):200–8. 30375905 10.1080/0284186X.2018.1529422 25. Niemierko A A generalized concept of equivalent uniform dose (EUD) Med Phys 1999 26 1100 10.1118/1.598063 Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys. 1999;26:1100. 10.1118/1.598063. 26. Wang H Cooper BT Schiff P Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans Br J Radiol 2018 92 1094 10.1259/bjr.20180471 PMC6404826 30209959 Wang H, Cooper BT, Schiff P, et al. Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans. Br J Radiol. 2018;92:1094. 10.1259/bjr.20180471. 10.1259/bjr.20180471 PMC6404826 30209959 27. Kutcher G Burman C Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method Int J Radiat Oncol Biol Phys 1989 16 1623 30 10.1016/0360-3016(89)90972-3 2722599 Kutcher G, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989;16:1623–30. 10.1016/0360-3016(89)90972-3. 2722599 10.1016/0360-3016(89)90972-3 28. Guangying Z Tingyi X Lvhua W Consensus and controversies on delineation of radiotherapy target volume for patients with non-small cell lung cancer Chin J Rasiat Oncol 2008 17 6 432 6 Guangying Z, Tingyi X, Lvhua W, et al. Consensus and controversies on delineation of radiotherapy target volume for patients with non-small cell lung cancer. Chin J Rasiat Oncol. 2008;17(6):432–6. 29. Barkati M Simard D Taussky D Magnetic resonance imaging for prostate bed radiotherapy planning: an inter- and intra-observer variability study J Med Imaging Radiat Oncol 2016 60 255 9 10.1111/1754-9485.12416 26568515 Barkati M, Simard D, Taussky D, et al. Magnetic resonance imaging for prostate bed radiotherapy planning: an inter- and intra-observer variability study. J Med Imaging Radiat Oncol. 2016;60:255–9. 10.1111/1754-9485.12416. 26568515 10.1111/1754-9485.12416 30. Yang J Beadle BM Garden AS Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy Pract Radiat Oncol 2014 4 1 e31 7 10.1016/j.prro.2013.03.003 24621429 Yang J, Beadle BM, Garden AS, et al. Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy. Pract Radiat Oncol. 2014;4(1):e31–7. 10.1016/j.prro.2013.03.003. 24621429 10.1016/j.prro.2013.03.003 31. Kuo Men X Chen Y Zhang Deep deconvolutional neural network for target segmentation of nasopharyngeal cancer in planning computed tomography images Front Oncol 2017 7 315 10.3389/fonc.2017.00315 29376025 PMC5770734 Kuo Men X, Chen Y, Zhang, et al. Deep deconvolutional neural network for target segmentation of nasopharyngeal cancer in planning computed tomography images. Front Oncol. 2017;7:315. 10.3389/fonc.2017.00315. PMID: 29376025; PMCID: PMC5770734. 29376025 10.3389/fonc.2017.00315 PMC5770734 32. Thibault Marin Y, Zhuo RM, Lahoud et al. Deep learning-based GTV contouring modeling inter- and intra- observer variability in sarcomas, radiotherapy and oncology, 167, 2022, Pages 269–276, ISSN 0167–8140, 10.1016/j.radonc.2021.09.034 10.1016/j.radonc.2021.09.034 PMC8934266 34808228 33. Lang DM, Peeken JC, Combs SE et al. Deep learning based GTV delineation and progression free survival risk score prediction for head and neck cancer patients. Lecture Notes in Computer Science, vol 13209. Springer, Cham. 10.1007/978-3-030-98253-9_14 34. Shi F Hu W Wu J Deep learning empowered volume delineation of whole-body organs-at-risk for accelerated radiotherapy Nat Commun 2022 13 6566 10.1038/s41467-022-34257-x 36323677 PMC9630370 Shi F, Hu W, Wu J, et al. Deep learning empowered volume delineation of whole-body organs-at-risk for accelerated radiotherapy. Nat Commun. 2022;13:6566. 10.1038/s41467-022-34257-x. 36323677 10.1038/s41467-022-34257-x PMC9630370 35. Zijdenbos AP, Dawant BM, Margolin RA, Palmer AC. Morphometric analysis of white matter lesions in MR images: method and validation. IEEE Trans Med. 1994 13(4):716–24. 10.1109/42.363096 10.1109/42.363096 18218550 ",
  "metadata": {
    "Title of this paper": "Deep learning empowered volume delineation of whole-body organs-at-risk for accelerated radiotherapy",
    "Journal it was published in:": "BMC Cancer",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482668/"
  }
}